Dana MD - Actinogen Medical Chief Board

ACW Stock

0.02 0 4.00%

Executive

Dana MD is Chief Board of Actinogen Medical

Age	71
Address	109 Pitt Street, Sydney, NSW, Australia, 2000
Phone	61 2 8964 7401
Web	https://actinogen.com.au

Actinogen Medical Management Efficiency

The company has return on total asset (ROA) of (0.4537) % which means that it has lost $0.4537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7881) %, meaning that it generated substantial loss on money invested by shareholders. Actinogen Medical's management efficiency ratios could be used to measure how well Actinogen Medical manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 1.4 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 11.2 M in 2024.

Compare Actinogen Medical to Peers

Predict price of Actinogen Medical

Actinogen Medical has accumulated 319.07 K in total debt. Debt can assist Actinogen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Actinogen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Actinogen Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Actinogen to invest in growth at high rates of return. When we think about Actinogen Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			EXECUTIVE Age
	Steve Maidment	Rea Group	N/A
	Nicole Reid	Xero	N/A
	BEc FCIS	Xero	N/A
	Mark Rees	Xero	N/A
	Jennifer Hornery	Cochlear	N/A
	Sivan Whiteley	Block Inc	47
	Kul Singh	Rea Group	N/A
	BComm CPA	Pro Medicus	N/A
	Alexander Schirmeister	Xero	N/A
	Rob McGrory	Cochlear	N/A
	Kristina Devon	Cochlear	N/A
	Nikhil Dixit	Block Inc	N/A
	Nicole Mehalski	Xero	N/A
	Joseph Lyons	Xero	N/A
	Alyssa Henry	Block Inc	54
	Chrysty Esperanza	Block Inc	N/A
	Nick Zangari	Light Wonder	N/A
	Mike Brock	Block Inc	N/A
	Brian Grassadonia	Block Inc	41
	Narelle Lynch	Tamawood	N/A
	Sean Lambright	Pro Medicus	N/A

Actinogen Medical (ACW) is traded on Australian Securities Exchange in Australia and employs 11 people. Actinogen Medical is listed under Biotechnology category by Fama And French industry classification.

Management Performance

	Return On Equity	-0.79
	Return On Asset	-0.45

Actinogen Medical Leadership Team

Elected by the shareholders, the Actinogen Medical's board of directors comprises two types of representatives: Actinogen Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Actinogen. The board's role is to monitor Actinogen Medical's management team and ensure that shareholders' interests are well served. Actinogen Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Actinogen Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.

	MBBS FRACP, CEO MD
	DCPSA FFPM, Chief Officer
	BCom IPAA, Chief Officer
	MAppFin BFinAdmin, Chief Officer
	BBus FCIS, Company Sec
	Michael Roberts, Head Communications
	Christian Toouli, Head Devel
	Fujun Li, Head Manufacturing
	Therese Russell, Head Infrastructure
	Tamara Miller, VP Devel
	Dana MD, Chief Board

Actinogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Actinogen Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.79
	Return On Asset	-0.45
	Profit Margin	(1.31) %
	Operating Margin	(0.18) %
	Current Valuation	69.19 M
	Shares Outstanding	3.13 B
	Shares Owned By Insiders	15.35 %
	Shares Owned By Institutions	7.28 %
	Price To Book	3.98 X
	Price To Sales	7.57 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Actinogen Stock Analysis

When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC